Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00202267
Other study ID # MCT 63175
Secondary ID 394622
Status Completed
Phase Phase 2
First received September 16, 2005
Last updated November 18, 2015
Start date January 2004
Est. completion date December 2008

Study information

Verified date November 2015
Source Queen's University
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Leg ulcers are emotionally distressing and painful, and often require months or years to heal. Although rarely acknowledged as a pressing health care issue, leg ulcers comprise a common, complex, and costly condition, managed primarily through community home care services. Indeed, leg ulcers are the most frequently seen and treated chronic wound. There is consensus in recent international, evidence-based practice guidelines that graduated, multi-layer compression is the most effective treatment, and greatly reduces healing time. High compression is more effective than low compression. However, there is no clear evidence as to which high compression technology is the most effective in promoting healing, the most acceptable to patients, or the most cost-effective to the health care system. This study is designed to answer these questions through a randomized trial conducted in the community, where most leg ulcer care currently takes place. Issues such as effectiveness in healing, quality of life, physical discomfort, personal preference, cost to the system and to the individual will be taken into consideration in evaluating two most commonly used types of compression bandaging.


Description:

Background:

Although rarely recognized as a pressing health care problem, leg ulcers comprise a common, complex, and costly condition. Over 80% of ongoing management of chronic wounds occurs in the community, and leg ulcers are one of the most frequently seen chronic wounds. The cost of leg ulcer care is considerable, being reported in both the UK and France to account for 2% of their total national health budgets. In Canada, the impact is only now being recognized due to the pressure on home care caseloads resulting from hospital downsizing, nursing shortages, and growing numbers of complex health populations. In one Ontario study, the care for fewer than 200 community leg ulcer cases cost in excess of $1.5 million for supplies and nursing visits, which translates to $100s of millions yearly Canada-wide. The impact on the individual is significant--chronic, painful, and often takes years to heal. Two-thirds of individuals with leg ulcers have at least one recurrence, and 45% have a history with the condition dating back 10 years.

State of Knowledge & Clinical Practice Guidelines:

Over the past decade, evidence from RCT studies and a recent Cochrane systematic review in BMJ demonstrated that venous leg ulcers treated with compression therapy are more likely to heal. Multi-layer high compression systems are more effective than low compression. However, the small number of people in trials comparing different high compression systems meant the review was unable to draw conclusions about their relative merit. Four of these trials have compared 4-layer bandage with short stretch technologies--the most commonly used technologies in Canada. In total, these trials involved only 220 patients, and were thus underpowered. Furthermore, they did not consider factors such as client preference and ease of use, or incorporate an economic evaluation.

Plan of Investigation:

The study will be a multi-centre, pragmatic, randomised trial of two types of compression bandaging technologies, incorporating an economic evaluation.

Research objective: To compare the effectiveness of 2 high compression technologies delivered in the community on ulcer healing, recurrence rates, quality of life, and cost-effectiveness.

Interventions: Four-layer bandage vs. Short-stretch bandage. Sample size: 414 total, 207 in each arm (80% power, " 0.05 to detect 4 week difference in time to heal).

Inclusion Criteria: leg ulcer>1 cm in any one dimension, minimum duration of 1 week, ABPI>0.7.

Randomization: will be carried out and stratified by: Clinical Centre (3 Health Regions in Ontario); Margolis' Prognostic Model (ulcer area and duration), Ulcer episode (1st or recurrent ulcer).

Analysis: Primary outcome: time-to-healing of the reference ulcer.

Secondary outcomes: quality of life & expenditures for treatment. Durability of healing will be assessed—follow-up for up to 52 weeks post-healing to determine recurrence rates associated with both technologies.

Summary:

There is consensus internationally in recommending the application of graduated multi-layer compression. High compression is more effective than low compression; however, there is no clear evidence as to which high compression technology is more effective.


Recruitment information / eligibility

Status Completed
Enrollment 426
Est. completion date December 2008
Est. primary completion date March 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- clinical presentation of venous insufficiency

- leg ulcer equal to or larger than 0.7 cm in any one dimension

- ulcer a minimum duration of 1 week

- ankle brachial pressure index equal to or greater than 0.80

- participant can provide written consent

- participant can communicate in English, or translation available

- participant 18 years or over

Exclusion Criteria:

- diagnosed with Diabetes Mellitus - insulin dependent or participant on oral hypoglycemics

- participants who failed to improve over a 3-month period after being treated with either the SS or 4-layer compression bandaging system prior to the trial

- previous trial patients (ie individuals previously enrolled in the study but now have recurrence or a new ulcer)

- symptoms of cognitive impairment noted

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Four-layer Bandage (Elastomeric)
Precise components of the four-layer system depend on the circumference of the ankle. All the bandages are discarded after a single use, usually one week.
Short-stretch Bandage (Non-elastomeric)
These bandages are applied in a figure-eight technique; two bandages are applied at full extension in opposite directions up the leg (i.e., clockwise and counter clockwise). The participant will wash the short-stretch wherever possible and reused. The number of bandages supplied to each patient will be recorded on the visit record.

Locations

Country Name City State
Canada Nursing Practice Solutions Fort Erie Ontario
Canada VON Hamilton Branch Hamilton Ontario
Canada Kingston Chronic Wound Clinic Kingston Ontario
Canada ParaMed Health Services Kingston Ontario
Canada Saint Elizabeth Health Care Kingston Ontario
Canada ET Now Kitchener Ontario
Canada Carefor Ottawa Ontario
Canada ParaMed Health Services Ottawa Ontario
Canada Ostomy and Wound Care Centre Regina Saskatchewan
Canada Saskatoon Health Region Home Care Saskatoon Saskatchewan
Canada St. Joseph's Care Group Thunder Bay Ontario
Canada Comcare Health Toronto Ontario
Canada ParaMed Home Health Care Toronto Ontario
Canada St. Michael's Hospital Toronto Ontario
Canada Winnipeg Regional Health Authority Winnipeg Manitoba

Sponsors (2)

Lead Sponsor Collaborator
Queen's University Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary 4 weeks or greater improvement in time-to-healing with short-stretch bandages compared to the four-layer bandaging system Time to healing or up to 12 months; post-healing follow-up No
Secondary rate of reduction in ulcer area Baseline and time of healing No
Secondary quality of life Baseline and every 3 months No
Secondary expenditures over a one-year follow-up From baseline to time of healing No
Secondary Recurrence Status recorded at last visit of each month; one year post-healing follow-up No
See also
  Status Clinical Trial Phase
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Recruiting NCT02838784 - Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers N/A
Completed NCT02092870 - Adipose Derived Regenerative Cellular Therapy of Chronic Wounds Phase 2
Terminated NCT00847002 - Flexitouch Treatment for Venous Ulcers N/A
Completed NCT01858272 - Preliminary Testing of New Treatment for Chronic Leg Wounds Phase 1
Not yet recruiting NCT05877378 - Efficacy of PICO Single-use System in Chronic Ulcers N/A
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Terminated NCT01396304 - Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers Phase 4
Not yet recruiting NCT06007703 - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Completed NCT04046120 - Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers N/A
Terminated NCT04021316 - Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration N/A
Completed NCT05729334 - Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions N/A
Completed NCT03070938 - PuraPly™ Antimicrobial Wound Matrix and Wound Management N/A
Terminated NCT01853384 - Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers Phase 3
Completed NCT00558662 - Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers N/A
Completed NCT01750749 - Cell Therapy for Venous Leg Ulcers Pilot Study Phase 1
Completed NCT01327937 - A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers Phase 4
Completed NCT00820196 - A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study) Phase 2
Completed NCT00301496 - Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers N/A
Recruiting NCT05489588 - The GORE® VIAFORT Vascular Stent Iliofemoral Study N/A